CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- 4 Open-market buy Senior VP, COO & CFO bought 5,400 shares at $4.45 ($24,041)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $4.40 ($43,962)
- 3 Insider Initial Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Exercise or conversion Chief Executive Officer acquired 49,600 shares (option exercise)
- 4 Open-market sale Vice President & Secretary sold 27,128 shares at an average $7.52 ($204,063)
- 4 Exercise or conversion Vice President & Secretary acquired 125,000 shares (option exercise)
- 4 Option exercise Director acquired 1,037,058 shares (option exercise)
- 4 Option exercise 10% owner acquired 115,520 shares (option exercise)
- 4/A Option exercise 10% owner acquired 220,086 shares (option exercise)
- 4 Option exercise Vice President & Secretary acquired 21,586 shares (option exercise)
- 4 Option exercise 10% owner acquired 220,086 shares (option exercise)
- 4 Insider Changes in Ownership
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 447,004 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 60,000 shares at an average $4.45 ($267,178)
- 4 Exercise or conversion Chief Financial Officer acquired 80,000 shares (option exercise)
- 4 Option exercise Vice President & Secretary acquired 23,750 shares (option exercise)
- 4 Option exercise 10% owner acquired 680 shares (option exercise)
Page 20 of 37 · 722 filings